EMERYVILLE, Calif., Sept. 20, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the B. Riley FBR Annual Consumer & Media Conference to be held

MANHASSET, N.Y., Sept. 20, 2019 /PRNewswire/ -- Feinstein Institutes for Medical Research scientists have been awarded a five-year,

SAN FRANCISCO, Sept. 20, 2019 /PRNewswire/ -- InsightRX, a pioneer in precision medicine, announced today the closing of its $10 million Series A funding led by HealthX Vent

MEMPHIS, Tenn., Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. de

BOSTON, Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announ

DEERFIELD BEACH, Fla., Sept. 20, 2019 /PRNewswire/ -- According to a recent Qualtrics Survey conducted September 4th though September 11th, of over 200 respondents with mild to moderate sleep apnea, more than 70% said they would prefer to try the FDA cleared Bongo Rx over traditional CPAP therapy to treat their

TITUSVILLE, N.J., Sept. 20, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today important new real-world evidence confirming XARELTO® (rivaroxaban) reduced the risk of recurrent venous thromboembolism (VTE) – or blood clots – in patients who are morbidly obese, with effectiveness and safety si

DEERFIELD BEACH, Fla., Sept. 20, 2019 /PRNewswire/ -- All Star Recruiting marked its annual Gratitude Day celebration by effecting its purpose, "All Star cares." Along with spreading appreciation and joy throughout the office, its people embraced the goal of raising at least $10,000 to send a child and his/her family on a Jorge Nation F

TOKYO, Sept. 20, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the oral once-daily therapy XOSPATA

NEW YORK, Sept. 20, 2019 /PRNewswire/ -- EyeJust announced the launch of blue light blocking screen protectors for iPhone 11, iPhone 11 Pro, and iPhone 11 Pro Max, designed to help consumers avoid harmful effects of blue light. The eye-opening truth is: harmful blue light is damaging your eyes, sleep and prematurely aging your skin. Blue light kills photoreceptor ce